AMSTERDAM and BARCELONA, Spain, April
19, 2018 /PRNewswire/ -- Royal
Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, is showcasing its integrated radiation oncology
solutions in the exhibition at the European Society for Radiation
Oncology's (ESTRO) 37th Annual Meeting in Barcelona, Spain. Focused on enhancing
precision therapy delivery, optimizing radiation dose management
and reducing time to treatment, Philips' dedicated radiation
oncology solutions help deliver more accurate, comprehensive
treatment plans. In addition, Philips is announcing a collaboration
with Sun Nuclear to integrate its suite of PlanIQ™ software with
Philips' Pinnacle3 16.2 Auto-Planning to aid clinicians
in establishing feasible treatment goals.
"Today's radiation oncology treatment planning processes are
still fragmented, labor-intensive and time-consuming, potentially
producing inconsistent results and delaying the start of
treatment," said Ardie Ermers,
General Manager Radiation Oncology, Philips. "Creating a
patient-specific treatment plan that is designed around a robust
assessment of the patient is essential. By integrating innovative
tools, systems and software, Philips helps improve care delivery,
time-to-treatment and overall patient satisfaction."
To further its mission in radiation oncology treatment planning,
Philips is collaborating with Sun Nuclear to integrate its suite of
PlanIQ™ software with Pinnacle3 16.2 Auto-Planning.
Based on each patient's own anatomy, PlanIQ uses unique, patented
technology to provide the clinician with achievable,
patient-specific goals for the treatment plan. Integrated with
Pinnacle3 Auto-Planning, a personalized treatment plan
can be created more efficiently.
"We are pleased to partner with Philips to bring the powerful
capabilities of PlanIQ to the Pinnacle3 user community,"
said Jeff Simon, Sun Nuclear's Chief
Executive Officer. "This is an exciting opportunity for both of our
organizations to advance radiation therapy quality and strengthen
overall patient safety, while providing radiation oncology teams
with a best-in-class solution to efficiently achieve accurate,
personalized plans."
ESTRO exhibition highlights
At the exhibition at this
year's ESTRO conference, Philips is highlighting a portfolio of
solutions to help enable a confident path to treatment focused on
the key areas of imaging and simulation, treatment planning, and
tumor follow-up and response. With integrated tools, systems and
software that span from imaging to treatment planning, Philips'
Radiation Oncology Solutions help improve patient care, accelerate
time to treatment and enhance patient satisfaction, while
maximizing the value of a provider's investment.
Imaging and simulation
For imaging and simulation,
Philips' iPatient for Big Bore CT provides a patient-centered
imaging workflow that helps drive consistency in image quality from
one scan to the next across diverse patient populations, which is
particularly relevant for cancer patients. The iPatient platform
provides a standardized approach to imaging simulation with
advanced 4D imaging applications, making patient setup fast and
easy while ensuring image quality and precision. The recently
announced IQon Spectral CT Elite features enhanced tumor
characterization, providing diagnostic certainty for oncology
clinicians and their patients, as well as a new radiation therapy
planning couch.
The Philips Ingenia MR-RT platform is the world's first MR
system with a commercial MR-only simulation package, leading a
paradigm shift in radiotherapy planning. With the planned extension
of MR-only simulation to include general pelvic soft-tissue cancers
[1] including rectal, bladder, gynecological and prostate, Philips
is committed to expanding the impact of this innovation and
simplifying MR-based planning workflows.
Philips is the MR-technology partner of Elekta and its MR-linac
system. Elekta's MR-linac is the only system that integrates an
advanced linear accelerator with cutting-edge, high-field (1.5
Tesla) magnetic resonance imaging without compromising either
system. Philips' MR simulation package for Elekta MR-linac [2] is
designed to exploit the many similarities and synergies between the
Philips Ingenia MR-RT and Elekta MR-linac to provide consistent
workflows and image quality from MR simulation through online MR
guidance during radiation treatment. A common high-field image
generation technology enables similar image quality and the same MR
console user interfaces, coil setup and patient positioning
workflows. This helps enhance reproducibility, accelerate learning
curves and drive continuity across the care pathway.
Treatment planning
Philips' leading radiation
treatment planning solutions include Pinnacle3 16.2 with
Auto-Planning, featuring advanced automated tools that reduce the
total time required to create IMRT or VMAT plans.
Pinnacle3 helps clinicians make effective decisions
based on changes in the patient anatomy and dose exposure. It was
recently installed alongside IBA's Proteus®ONE proton therapy
system at Proton Partners International's Rutherford Cancer Centre
in South Wales, the first ever to
provide High Energy Proton Therapy in the UK.
Tumor follow-up and response
IntelliSpace Portal 10 is
an advanced visualization and analysis solution designed to give
radiologists a comprehensive clinical view while helping them work
quickly and reducing variance in analysis – offering Tumor Analysis
and Treatment Response tools with a streamlined workflow for
follow-up and analysis of oncology patients. Advanced visualization
and analysis tools provide the ability to easily pair all Philips
modalities and healthcare IT solutions.
Philips Vereos Digital PET/CT, the world's first and only fully
digital PET/CT system, delivers improved detectability and
characterization of small lesions [3]. The system offers
uncompromised detectability and quantification at half the PET dose
[4] and also provides improved lesion detectability in one tenth of
the time [5]. Vereos simplifies the path to clinical decision
making through a faster, more confident path to cancer
treatment.
For more information about Philips' presence at the show,
including the full suite of Philips radiation oncology technology
and integrated solutions, visit Philips at booth #1300 at ESTRO or
at the Philips ESTRO event website. For live updates throughout
#ESTRO37, follow @PhilipsLiveFrom.
[1] MR-only simulation for general pelvis is considered work in
progress, is not CE marked yet and is not available for sale or
distribution.
[2] The MR simulation package and the Elekta MR-Linac are work in
progress and not available for sale or distribution.
[3] Nguyen NC, Image Quality and Diagnostic Performance of a
Digital PET Prototype in Patients with Oncologic Diseases: Initial
Experience and Comparison with Analog PET, J Nucl Med 2015;
56:1378–1385.
[4] Liu X et al, Impact of FDG Dose Reduction on Lesion
Quantification in Dynamic PET: A Simulation Study Based on Clinical
Trial Data, SNMMI 2016.
[5] Zhang J., Evaluation of speed of PET acquisition: How fast can
we go? - A validation of list mode PET simulation approach with
true acquisitions, SNMMI 2017.
For further information, please contact:
Mark Groves
Philips Group Press Office
Tel.: +31 631 639 916
E-mail: mark.groves@philips.com
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring and
health informatics, as well as in consumer health and home care.
Philips' health technology portfolio generated 2017 sales of
EUR 17.8 billion and employs
approximately 74,000 employees with sales and services in more than
100 countries. News about Philips can be found at
http://www.philips.com/newscenter.
View original content with
multimedia:http://www.prnewswire.com/news-releases/philips-showcases-dedicated-radiation-oncology-workflow-solutions-spanning-image-acquisition-to-treatment-planning-at-estro-2018-300632678.html
SOURCE Royal Philips